U.S. Life Sciences Stock News

KB Home (KBH) recently issued fiscal fourth quarter results that included guidance for revenue below the prior year, sparking a 10% share price drop and cautious commentary on potential gross margin pressure. See our latest analysis for KB Home. Despite the post earnings drop, KB Home’s recent news flow has included new community openings in California and a planned board transition. The 7 day share price return of 9.42% contrasts with a 1 year total shareholder return decline of 5.26%,...

Recently, Rush Enterprises reported quarterly results showing flat year-on-year revenue but a clear beat versus analysts’ expectations, including stronger-than-expected EBITDA, despite ongoing headwinds in the commercial vehicle industry such as soft freight demand, overcapacity, tariffs, and broader economic uncertainty. An interesting angle is that modest growth in higher-margin aftermarket activity and light-duty vehicle sales underpinned this earnings outperformance, highlighting the...

Cushman & Wakefield recently appointed Andy Jansen as President of Project & Development Services for the Americas, effective January 5, 2026, tasking him with leading vision, technology implementation, and sales methodology for the business. Jansen’s background in graph-based technology at NEO4J and his BuiltWorlds co-founding experience introduces a technology-focused approach to Cushman & Wakefield’s project and development services offering. We’ll now examine how Jansen’s...

ACI Worldwide (ACIW) is in focus after announcing it will integrate Early Warning Services’ Paze online checkout into its Pay.On payment orchestration platform, widening digital wallet access for U.S. merchants and consumers. See our latest analysis for ACI Worldwide. The Paze announcement comes after a stretch where momentum has cooled, with a 90 day share price return of 9.68% and a 1 year total shareholder return of 12.92%, set against a stronger 3 year total shareholder return of...

Agios Pharmaceuticals recently outlined its 2026 strategic priorities at the 44th Annual J.P. Morgan Healthcare Conference, emphasizing the ongoing U.S. launch of AQVESME (mitapivat) in thalassemia following its December 2025 FDA approval and upcoming regulatory interactions for mitapivat in sickle cell disease. This update underscores how Agios is working to convert its rare disease pipeline into commercial momentum by expanding mitapivat’s reach across multiple hematologic...

Kahn Swick & Foti, LLC recently reminded ICON investors of an approaching deadline to apply for lead plaintiff status in a securities class action, tied to alleged disclosure failures between July 27, 2023 and October 23, 2024. The reminder revives focus on ICON’s October 2024 revenue shortfall disclosure and could keep legal and regulatory risk firmly in the spotlight for investors. We’ll now examine how this renewed focus on potential disclosure and legal risks may influence ICON’s...

Xenon Pharmaceuticals (XENE) has been drawing attention after recent trading, with the share price at US$40.36 and mixed returns over the past year, including a small one-year gain and a negative year to date. See our latest analysis for Xenon Pharmaceuticals. Recent trading has been softer, with a 1 month share price return showing an 8.4% decline and a year to date share price return showing a 9.3% decline, even though the 5 year total shareholder return of 152.7% points to much stronger...

In recent days, TKO Group Holdings has seen insider share sales by senior executives, including transactions executed under pre-arranged Rule 10b5-1 trading plans. At the same time, management has publicly highlighted confidence in surpassing 2025 performance projections and raised long-term sponsorship revenue ambitions toward 2030. We’ll now examine how management’s increased sponsorship revenue ambitions shape TKO Group Holdings’ investment narrative in light of recent developments...

Federal Agricultural Mortgage (AGM) has drawn investor attention after recent share price weakness, with the stock showing negative returns over the past week, month, and year, despite positive annual revenue and net income growth figures. See our latest analysis for Federal Agricultural Mortgage. At the current share price of $167.31, Federal Agricultural Mortgage’s recent 1 day and 1 month share price declines sit against a 3 year total shareholder return of 49.4% and a 5 year total...

In the past few days, Hertz Global Holdings learned it must pay more than US$270 million in make-whole premiums and interest to former bondholders after the US Supreme Court declined to review its bankruptcy-related appeal, leaving the lower court ruling in place. This ruling adds a sizable new liability on top of Hertz’s already high debt load, intensifying concern about its financial flexibility and legal overhangs. Next, we’ll examine how this additional US$270 million obligation could...

Stewards at Sequire Investor Summit: Why This Event Matters Stewards (SWRD) is set to present at the Sequire Investor Summit 2026 in Puerto Rico, where management plans to outline its diversified operating platform and its progress toward a potential uplisting to the Nasdaq Capital Market. See our latest analysis for Stewards. The upcoming Sequire presentation comes after a choppy period for the stock, with a 1-day share price return of 5.26% contrasting with a 7-day decline of 15.25% and a...

Palladyne AI (PDYN) is back in focus after raising its 2026 revenue outlook to US$24.0 million to US$27.0 million, supported by recent acquisitions and growing interest around its newly launched Palladyne IQ 2.0 platform. See our latest analysis for Palladyne AI. The 47.31% 30 day share price return and 51.06% year to date share price return suggest momentum has been building recently, even though the 1 year total shareholder return of a 21.13% decline shows longer term holders are still...

In early 2026, Dollar General expanded its Nashville-area headquarters with an US$8.30 million, three-story office building and continued rolling out hundreds of new and remodeled stores across the U.S. to support its mission of Serving Others. At the same time, upbeat commentary from Wall Street analysts and media voices highlighted Dollar General as a standout among dollar stores, emphasizing operational improvements and sector appeal rather than short-term market moves. Next, we’ll...

UFP Technologies, Inc. ( NASDAQ:UFPT ), might not be a large cap stock, but it received a lot of attention from a...

Sherwin-Williams (SHW) is back in focus after recent trading, with the stock closing at $355.99 and posting mixed short term returns, including a 0.5% decline over the past day and gains across longer periods. See our latest analysis for Sherwin-Williams. That 0.5% one day share price pullback comes after a stronger run, with a 7 day share price return of 4.7% and a year to date share price return of 8.6%, while the 5 year total shareholder return of 53.9% points to momentum that has...

If you are wondering whether Boyd Gaming's current share price lines up with its underlying worth, you are not alone. This article focuses squarely on what you are paying versus what you are getting. The stock recently closed at US$88.03, with returns of 0.3% over 7 days, 3.4% over 30 days, 2.1% year to date, 22.2% over 1 year, 52.7% over 3 years, and 92.3% over 5 years. These figures can influence how investors think about its future potential and risk. Recent coverage of Boyd Gaming has...

In recent days, Apple confirmed a multi-year partnership to base its next generation of Apple Foundation Models and an upgraded Siri on Google’s Gemini AI models and cloud technology, while Alphabet’s market value briefly crossed US$4.00 trillion as investors focused on its expanding AI footprint. This collaboration places Alphabet’s Gemini at the core of AI experiences across billions of Apple devices, reinforcing Google Cloud and Gemini as critical infrastructure for consumer and...

Teradata (TDC) has been attracting fresh attention after recent share price moves, with the stock showing mixed short term performance but notable gains over the past 3 months, prompting investors to reassess its data analytics business. See our latest analysis for Teradata. That 46.71% 90 day share price return contrasts with a 5.05% year to date share price gain and a 1.83% one year total shareholder return, suggesting momentum has picked up recently even though longer term results remain...

Lattice Semiconductor recently presented at the 28th Annual Needham Growth Conference in New York, featuring remarks from CEO Ford Tamer, CFO Lorenzo A. Flores, and Senior Director of Investor Relations Rick Muscha. The conference appearance, paired with fresh analyst commentary and renewed enthusiasm for artificial intelligence and broader technology themes, has sharpened investor focus on how Lattice’s role in these areas could influence its longer-term business outlook. With that backdrop...

If you are wondering whether Janus Henderson Group stock still offers value at around US$47.86, this article walks through what the current price might be implying about the business. The share price has moved by 0.4% over the last week, 5.2% over the last month, 0.2% year to date and 21.5% over the last year, with a very large 3 year return and a 78.4% return over 5 years that may catch the eye of long term holders. Recent coverage has focused on how asset managers are responding to shifts...

At CES 2026, PepsiCo announced a multi-year collaboration with Siemens and NVIDIA to apply AI-driven digital twin technology to its manufacturing plants and supply chain, using high-fidelity 3D simulations to redesign and optimize facilities before making physical changes. Early U.S. pilots reportedly uncovered hidden capacity, lifted throughput and reduced capital needs, highlighting how virtual testing could reshape how PepsiCo plans and upgrades its global production footprint. We’ll...

If you are wondering whether Ocular Therapeutix at around US$10.43 offers good value or too much risk, this breakdown is designed to help you make sense of the numbers. The stock has been volatile recently, with a 7.3% decline over the last week and a 28.4% decline over the last month, although it is still up 32.7% over the past year and 152.5% over three years. Over five years, the return sits at a 48.1% decline. Recent attention on Ocular Therapeutix has focused on its pipeline progress...

In December 2025, FTAI Aviation launched FTAI Power, a new platform that repurposes CFM56 aircraft engines into power turbines to provide flexible, cost-efficient energy solutions for data centers worldwide. This move extends FTAI’s legacy engine expertise into the fast-growing data center power market, potentially broadening its revenue base beyond aviation services. Next, we’ll explore how entering the data center power market through FTAI Power could reshape FTAI Aviation’s legacy...

SiTime (SITM) is set to present at the 28th Annual Needham Growth Conference on January 13, 2026. This event gives investors fresh insight into the company’s silicon timing solutions business. See our latest analysis for SiTime. SiTime’s recent 1-day share price return of 1.77% and 90-day share price return of 20.91% sit alongside a 1-year total shareholder return of 50.51% and 3-year total shareholder return above 2x, suggesting momentum has been building even after some shorter term share...